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Received 20 June 2016; revised 27 July 2016; accepted 29 July 2016AbstractTrimethyltin (TMT) is an occupational and environmental health hazard behaving as a potent neurotoxin known to affect the central nervous
system as well as the peripheral auditory system. However, the mechanisms underlying TMT-induced ototoxicity are poorly understood. To
elucidate the effects of TMT on the cochlea, a single injection of 4 or 8 mg/kg TMT was administered intraperitoneally to adult rats. The
compound action potential (CAP) threshold was used to assess the functional status of the cochlea and histological techniques were used to assess
the condition of the hair cells and auditory nerve fibers. TMT at 4 mg/kg produced a temporary CAP threshold elevation of 25e60 dB that
recovered by 28 d post-treatment. Although there was no hair cell loss with the 4 mg/kg dose, there was a noticeable loss of auditory nerve fibers
particularly beneath the inner hair cells. TMTat 8 mg/kg produced a large permanent CAP threshold shift that was greatest at the high frequencies.
The CAP threshold shift was associated with the loss of outer hair cells and inner hair cells in the basal, high-frequency region of the cochlea,
considerable loss of auditory nerve fibers and a significant loss of spiral ganglion neurons in the basal turn. Spiral ganglion neurons showed
evidence of soma shrinkage and nuclear condensation and fragmentation, morphological features of apoptotic cell death. TMT-induced damage
was greatest in the high-frequency, basal region of the cochlea and the nerve fibers beneath the inner hair cells were the most vulnerable structures.
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Chronic exposure to heavy metals and their organic de-
rivatives can cause serious and potentially lethal harm to
humans (Jarup, 2003; Prasher, 2009). Many heavy metals such
as lead, mercury, cadmium, arsenic, manganese, cobalt, plat-
inum and copper, which are widely used in manufacturing, are
neurotoxic leading to a diverse array of debilitating clinical
symptoms (Ding et al., 1999, 2007, 2009, 2011a, b, c; Bencko* Corresponding author. Center for Hearing and Deafness, State University
at Buffalo, Buffalo, NY 14214, USA. Fax: þ1 716 829 2980.
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1672-2930/Copyright © 2016, PLA General Hospital Department of Otolaryngolo
Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://cret al., 2009; Ikeda et al., 2010; He et al., 2011; Li et al., 2011;
Shargorodsky et al., 2011; Wu et al., 2011; Ding et al., 2012a,
Ding et al., 2012b; Hoshino et al., 2012; Ding et al., 2013; Liu
et al., 2014; Wang et al., 2014; Li et al., 2015). During
manufacturing, many heavy metals are inadvertently released
into the environment posing serious risk to the public. Tri-
methyltin (TMT) is a short-chain organotin compound,
notable for its deleterious effects on the central nervous system
(CNS) (Koczyk, 1996). In experimental animals, TMT expo-
sure selectively induces neuronal loss in the limbic system,
including the hippocampus, pyriform cortex, olfactory tuber-
cle, amygdala, and neocortex (Geloso et al., 2011). Rats
exposed to TMT by intraperitoneal injection, develop a syn-
drome characterized by seizures, tail mutilation, vocalizations,
hyperactivity, aggression, hearing loss and learninggy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
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which are known as the “TMT syndrome” (Dyer et al., 1982;
Clerici et al., 1991). Human TMT exposure, which typically
occurs by inhalation, produces a similar malady with disori-
entation, amnesia, aggressive behavior, ataxia, complex partial
seizures and hearing loss (Besser et al., 1987). TMT induced
neurobehavioral and neuropathological symptoms are similar
in some respects to other neurodegenerative disorders such as
Alzheimer's disease (AD) and temporal lobe epilepsy (TLE)
(Ishikura et al., 2002; Nilsberth et al., 2002). Accordingly,
TMT, frequently administered by intraperitoneal injection, is
often used as a tool for studying neuronal degeneration that is
associated with cognitive impairment and seizures (Besser
et al., 1987; Clerici et al., 1991; Geloso et al., 2011).
In addition to the neurotoxic effects in CNS, TMT is highly
ototoxic, producing hearing impairment even at very low
doses of exposure (Fechter and Liu, 1995). For example, a
single intraperitoneal injection of 2 mg/kg of TMT in guinea
pigs resulted in impaired hearing thresholds within 30 min of
administration (Clerici et al., 1991). The mechanisms under-
lying TMT-induced ototoxicity remain poorly understood.
TMT appears to directly damage the cochlea (Fechter et al.,
1986) reducing the cochlear microphonic (CM) amplitude,
which largely reflects the electromechanical response of outer
hair cells (OHC) as well as the compound action potential
(CAP), a neural response from the auditory nerve initiated at
the inner hair cells (IHC) and relayed across the afferent
synapse to the spiral ganglion neurons (SGN). These results
suggest that TMT could damage the OHC, IHC, the afferent
synapse and SGN (Clerici et al., 1991; Fechter et al., 1992).
However, the specific anatomical targets of TMT-induced
cochlear damage are still poorly understood. Recent in vitro
studies in our laboratory demonstrated that TMT preferentially
damages SGN and their peripheral afferent nerve fibers with
surprisingly little impact on the sensory hair cells in rat
cochlear organotypic cultures (Yu et al., 2015). These results
suggest that the SGN and auditory nerve fibers may be the
most susceptible to TMT-induced damage. To better under-
stand the mechanisms and in vivo cellular targets responsible
for TMT ototoxicity, rats were treated with 4 or 8 mg/kg of
TMT. The CAP was used to characterize the time course and
frequency-specific nature of the hearing impairment and their
cochleae harvested to determine the magnitude and location of
hair cell loss and damage to the auditory nerve fibers and
spiral ganglion neurons.
2. Materials and methods2.1. Animal treatmentFemale SpragueeDawley rats weighing between 250 and
350 g were used for this study. All animal procedures were
approved by the institutional animal care and use committee of
the Xiangya Hospital, Central South University. Thirty-two
animals with normal hearing were randomly divided into
three groups: control group (n ¼ 8), TMT 4 mg/kg treatment
group (n ¼ 12), and TMT 8 mg/kg treatment group (n ¼ 12).These doses we employed were somewhat higher than those in
the guinea pig, because rats tend to be less susceptible to
ototoxicants than guinea pig. Some rats were exclusive used
for anatomical studies while others were used for both histo-
logical analysis and CAP recordings. Rats in the two TMT-
treated groups received a single intraperitoneal (i.p.) injec-
tion of TMT at either 4.0 mg/kg or 8.0 mg/kg body weight.
TMTwas dissolved in 1.0 ml normal saline (concentration 4 or
8 mg/ml). Rats in control group received a single injection
(i.p.) of saline vehicle. Cochlear auditory function and histo-
pathologies were examined at various time intervals after
TMT treatment.2.2. CAPTo evaluate the changes in the CAP versus time after TMT
injection, a silver electrode was implanted into the facial nerve
canal via the stylomastoid foramen. Our surgical approach for
electrode implantation and procedure for CAP recording have
been described previously (Yu et al., 2014). Ophthalmic
ointment (Puralube Vet ointment, Dechra Veterinary Product)
was put on the cornea daily to prevent visual impairment
caused by facial paralysis after electrode implantation in facial
nerve canal. During CAP testing, rats were anesthetized with a
mixture of ketamine (50 mg/kg i.p.) and xylazine (6 mg/kg,
i.p.). Body temperature was maintained at 37 C using a
heating pad. The CAP was recorded using TDT system III
equipment (TuckereDavis Technologies, USA). Tone burst
stimuli at 4, 8, 16 and 32 kHz were digitally synthesized with a
3 ms duration and 0.5 ms rise-fall time and delivered at 21
times/s. Evoked potentials were filtered between 100 and
3000 Hz, and averaged 100 times. Thresholds were obtained
by reducing the sound intensity in 5 dB increments from 90 dB
SPL until the response completely disappeared. The lowest
sound level that elicited a reproducible N1 wave in the CAP
was defined as threshold. The amplitude of CAP stimulated by
tone burst at 4, 8, 16, 32 kHz at 80 dB (SPL) was measured.
The value of CAP from baseline to the peak of N1 wave was
defined as CAP amplitude. The latency of CAP stimulated by
tone burst at 4, 8, 16, 32 kHz was also measured. The time
from the onset of sound stimulus by 80 dB (SPL) tone burst to
the onset of the CAP was defined as CAP latency.2.3. Cochlear hair cell staining and quantificationsImmediately after completing the functional tests, the
anesthetized rat was decapitated. The cochleae were rapidly
removed and the oval and round windows and the apex
opened. The cochleae were perfused with a solution of suc-
cinate dehydrogenase (SDH, 2.5 ml of 0.2 M sodium succi-
nate, 2.5 ml of 0.2 M phosphate buffer, pH 7.6, and 5 ml of
0.1% tetranitro blue tetrazolium) and subsequently immersed
in the solution at 37 C for 45 min. Afterwards, the cochleae
were fixed in 10% formalin in PBS overnight. Under dissec-
tion microscope, the cochlear basilar membrane was carefully
dissected out and specimens were mounted on glass slides and
coverslipped. Hair cell counting was performed under a light
120 J. Yu et al. / Journal of Otology 11 (2016) 118e126microscope and individual cochleograms were constructed for
each ear by plotting the percent hair cell loss as a function of
percent distance from the apex of the cochlea. Individual
cochleograms were aggregated to generate a mean cochleo-
gram for each group using custom software.2.4. Immunostaining and histologyFor immunostaining, animals were anesthetized and
perfused transcardially with 10% formalin solution. Cochleae
were removed and fixed in the same fixative at 4 C for 2 h.
After rinsing in PBS, the whole basilar membrane containing
SGNs were dissected out and immersed in 10% goat serum
and 0.2%Trition X-100 in PBS for 2 h. The samples were
incubated overnight at 4 C with a monoclonal primary mouse
anti-neurofilament 200 antibody (Sigma, N0142) diluted in
PBS containing 1% Triton X-100 and 5% goat serum (1:100).
The following day specimens were rinsed three times with
PBS and incubated in a secondary goat anti-mouse antibody
conjugated with Alexa Fluor488 (Life technologies, A11001)
diluted in PBS (1:200) for 2 h. Specimens were subsequently
treated with the nuclear stain, To-Pro-3, (Life technologies,
T3605) for 30 min. Tissues were then mounted on glass slides
in glycerin, coverslipped, and examined under a confocal
microscope (Zeiss LSM-510).
For sectioning, cochleae were removed as above and fixed
in 2.5% glutaraldehyde overnight at 4 C. After decalcification
with 3% hydrochloric acid and further post-fixation in 1%
osmium, the cochleae were dehydrated through a gradient
alcohol and acetone series and embedded in Epon 812. The
cochleae were sectioned serially at a thickness of 4 mm parallel
to the cochlear modiolus as described previously (Wang et al.,
2003). Sections were collected on glass slides, stained with
toluidine blue, examined and photographed under a light mi-
croscope. The density of SGN was quantified using image J
software as previously described (Yu et al., 2014). The
boundary of the Rosenthal's canal was outlined and its cross-
sectional area was measured by image J software. The
numbers of SGN in Rosenthal's canal were counted and the
density of SGN was obtained by dividing the number of SGN
by the area of the area of Rosenthal's canal.2.5. Statistical analysisStatistical analyses were performed with GraphPad Prism
software (version 5) as described below with the significance
level set at p < 0.05.
3. Results3.1. CAP changes post-TMTTo evaluate the effect of TMT on cochlear function, the
CAP was recorded with the facial nerve canal electrode before
and then 30 min, 1, 7, 14, 21 and 28 days post-TMT exposure.
In the control group, CAP threshold did not change signifi-
cantly compared to pre-treatment values at any time point(data not shown). However, significant changes in thresholds,
amplitudes, and latencies of CAP were observed after the 4
and 8 mg/kg TMT treatments (Fig. 1). Mean (þ/ SEM) CAP
thresholds in 4 (n ¼ 5) and 8 mg/kg (n ¼ 6) TMT groups were
significantly elevated at 30 min post-TMT and continued to
increase out to 1 or 7 days post-TMT depending on dose and
frequency. At 7 d post-TMT, CAP threshold shifts in 4 mg/kg
group were about 60, 25, 25 and 20 dB at 32, 16, 8 and 4 kHz
respectively (Fig. 1A), but then declined at longer recovery
time so that CAP thresholds were back to near normal at 28 d
post-TMT. At 7 d post-TMT, CAP threshold shifts in the 8 mg/
kg group were roughly 65, 40, 45 and 30 dB at 32, 16, 8 and
4 kHz respectively (Fig. 1B). Threshold declined slightly be-
tween 7 and 14 d post-TMT and then either remained stable or
increased slightly out to 28 d post-TMT resulting permanent
CAP threshold shifts of approximately 60, 40, 25 and 20 dB at
32, 16, 8 and 4 kHz respectively.
A two-way repeated measures analysis of variance with
Bonferroni posttests were carried out on the CAP data
focusing on the change in threshold relative to baseline. For
the 4 mg/kg group there were significant main effects of fre-
quency (F ¼ 56.7; 3, 96 DF; p<<0.001), time (F ¼ 51.3; 6, 96
DF; p < 0.001) and the interaction of frequency and time
(F ¼ 2.06; 18, 96 DF; p < 0.0001). CAP threshold at 4 kHz
were significantly higher than baseline from 1 to 14 d post-
treatment (p < 0.05) but were back to normal at 21 and
28 d. Thresholds at 8 kHz were higher than normal between
30 min and 14 d post-treatment (p < 0.05), but were essen-
tially normal at 21 and 28 d post-treatment. Thresholds at
16 kHz and 32 kHz were significantly (p < 0.05) above
baseline between 30 min and 21 d post-treatment but were
within normal limits at 28 d post-treatment. In the 8 mg/kg
TMT group, there were significant main effects for frequency
(F ¼ 103.3; 6, 120 DF; p < 0.0001), time (F ¼ 64.2; 3, 12 DF;
p < 0.0001) and frequencyetime interaction (F ¼ 4.1; 20 120
DF; p < 0001). CAP thresholds at 4, 8, 16 and 32 kHz were
significantly higher than baseline from 30 min to 28 d post-
treatment.
In comparison with pre-testing, mean (þ/ SEM) CAP
amplitudes at 32, 16, 8, and 4 kHz measured at 80 dB (SPL) in
both 4 mg/kg (n ¼ 5) and 8 mg/kg (n ¼ 6). TMT groups were
significantly decreased 28 days post-TMT (Fig. 1C, D). Mean
(þ/ SEM) CAP latencies at 32, 16, 8, and 4 kHz at 80 dB
(SPL) did not changed significantly in 4 mg/kg TMT group
(Fig. 1E) 28 days post-TMT. However, the CAP latencies at all
frequencies were significantly delayed 28 days post-treatment
in the 8 mg/kg TMT group (Fig. 1F).3.2. Hair cell lossTo determine if TMT damaged hair cell, OHC and IHC
losses were evaluated 7 days post-TMT. Representative pho-
tomicrographs of SDH-stained surface preparations are shown
in Fig. 2A. In control cochleae the IHC and OHC were
intensely stained with SDH in the apical, middle and basal
turn of the cochlea. A similar pattern of SDH labeling was
observed in OHC and IHC in the 4 mg/kg TMT group.
Fig. 1. Changes in thresholds, amplitudes, and latencies of CAP before and after TMT treatment. A,B: Mean (þ/ SEM) CAP thresholds before, and 30 min, 1, 7,
14, 21, and 28 days following 4 mg/kg TMT treatment (n ¼ 5), or 8 mg/kg TMT treatment (n ¼ 6). C,D: Mean (þ/ SEM) CAP amplitude before, and 30 min, 1,
7, 14, 21, and 28 days following 4 mg/kg TMT treatment (n ¼ 5), or 8 mg/kg TMT treatment (n ¼ 6). E,F: Mean (þ/ SEM) CAP latencies before, and 30 min, 1,
7, 14, 21, and 28 days following 4 mg/kg TMT treatment (n ¼ 5), or 8 mg/kg TMT treatment (n ¼ 6).
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sent from almost all OHC as well as some IHC in the basal
turn. However, SDH labeling was present in most OHC and
IHC in the apical and middle turn. Mean (n ¼ 5) cochleograms
showing the percent missing OHC and IHC for the control
group and the 4 and 8 mg/kg TMT group are shown in Fig. 2B.
Average hair cell loss was less than 5% along the entire length
of the cochlea in the control group as well as in the 4 mg/kg
TMT group. In the 8 mg/kg TMT group, the mean OHC loss
decreased from about 60% at the 90% location to less than
10% loss at the 60% location. The mean IHC loss was
restricted to the extreme base and decreased from approxi-
mately 50% at the 90% location to less than 10% loss at the
80% location.3.3. Cochlear nerve fiber damageTo assess the effects of TMT on cochlear nerve terminals,
we immunostained the cochlea with an antibody against
neurofilament 200 kDa to reveal the peripheral nerve fibers in
the sensory epithelium. Fig. 4 illustrates the typical status of
cochlear nerve fibers in control and TMT-treated groups seven
days post-treatment. In controls, the nerve fibers exit the
habenula perforata and project out to the organ of Corti in a
well-organized pattern. Many nerve fibers end in the vicinity
of the IHC mostly near the basal pole. Based on the location of
neurofilament immunolabeling, the majority of these are pre-
sumably type I afferent auditory nerve fibers that comprise
90e95% of all afferents (Spoendlin, 1978), but some may be
Fig. 2. Hair cell loss after TMT treatment. (A) Representative photomicrographs (200X) of surface preparation from the apical, middle and basal turn of the
cochlea from the control group and 4 mg/kg and 8 mg/kg TMT groups 7 days post-treatment. Samples labeled with succinate dehydrogenase which intensely stains
the outer hair cells (OHC) and inner hair cells (IHC). Note significant loss of staining of OHC and IHC in the basal turn of the 8 mg/kg TMT group. (B) Mean
cochleograms (n ¼ 5/group) from the control group and the 4 and 8 mg/kg TMT groups. Cochleograms show the percent missing IHC and OHC as a function of
percent distance from the apex of the cochlea.
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Warr, 1983). A minority of the neurofilament-labeled fibers
crossing the tunnel of Corti and projecting to the three rows of
OHC are likely the medial olivocochlear efferent fibers and the
afferent processes of type II SGN (White and Warr, 1983;
Warr, 1992). In the 4 mg/kg TMT group, there were far fewer
neurofilament-labeled fibers in the IHC region and a reduction
in the number of fibers projecting to the OHC (Fig. 3B, b).
Some fibers in the 4 mg/kg TMT group were distorted and
looped in the tunnel of Corti rather than projecting radially
(arrowhead, Fig. 3B). In the 8 mg/kg TMT group, there was a
further reduction in the number of fibers in IHC region and
those projecting to the OHC region (Fig. 3C, c). Since most
OHCs were missing, some nerve fibers looped around and
crossed over one another (asterisk). .3.4. Spiral ganglion neuron degenerationThe survival of SGN was evaluated seven days after TMT
treatment from plastic embedded cross sections of theRosenthal's canal. Fig. 4AeC displays representative micro-
graphs of the SGN in Rosenthal's canal for the lower basal turn
of the cochlea from a representative control animal and ani-
mals from the 4 and 8 mg/kg TMT-groups. In the control
group, Rosenthal's canal was densely packed with SGNs and
thick fascicles of fibers (Fig 4A). In the 4 mg/kg TMT-group,
the number and the condition of the SGNs and auditory nerve
fibers (ANFs) appeared similar to the controls (Fig. 4B). In
contrast, severe loss of SGNs and ANFs was evident in the
lower basal turn of the cochlea in the 8 mg/kg TMT group,
particularly in the hook region. However, there was no evi-
dence of damage to SGN and ANFs in more apical regions of
the cochlea (data not shown). To quantify the results, SGN
counts were performed in the hook region of 5 control rats, 5
rats in 4 mg/kg TMT group and 6 rats in the 8 mg/kg TMT
group. SGN counts were measured with an area of
0.0144 mm2 at three locations within the hook region and
mean value computed for each rat. To compare the results, the
SGN density measures rats in the TMT group were normalized
to the control and expressed as a percentage of the controls. As
Fig. 3. Representative confocal images showing the condition of cochlear nerve fibers from the basal turn of the cochlea 7 d post-treatment. Nerve fibers labeled
with antibody against neurofilament 200 kDa (green); nuclei labeled with To-Pro-3 (blue). Surface preparation view (A) and (a) Z-plane image of the cochlea from
the control group. Note dense network of nerve fibers, mostly type I auditory nerve fibers, adjacent to the row of inner hair cells (IHC). Note thick fascicles of nerve
fibers, mostly type II auditory nerve fibers, projecting our radially towards the outer hair cells (OHC). Surface preparation view (B) and z-plane image of the
cochlea from a rat in the 4 mg/kg TMT group. Notes reduced nerve fibers adjacent to the IHC and reduced numbers of fibers projecting radially towards the OHC
(arrowheads). Surface preparation (C) and z-plane (c) image from the cochlea of a rat in the 8 mg/kg TMT group. Note diminished nerve fiber labeling near the
IHC, the reduction in the number of radial nerve fibers and loss of OHC nuclei (asterisks).
Fig. 4. Loss of spiral ganglion neurons (SGN) at 7 d post-TMT treatment. (AeC) Representative images (200X) of Rosenthal's canal taken from the basal turn of
the cochlea from a Control rat and rats treated with 4 mg/kg or 8 mg/kg TMT. (D) Histogram showing the mean (þ/ SEM) percent reduction in SGNs in the hook
region of the cochlea in the 4 mg/kg (n ¼ 5) and 8 mg/kg (n¼ 6) TMT groups relative to the Control group (n ¼ 5). There were significantly few SGNs in the 8 mg/
kg group compared to the control group and the 4 mg/kg group (*p < 0.05).
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8 mg/kg TMT group was significantly lower than the control
group and the 4 mg/kg TMT group (one-way ANOVA,
F ¼ 29.41, 2, 15 DF, p < 0.0001, NewmaneKeuls post-hoc
comparison, p < 0.05).
To gain insights into the mechanism of SGN degeneration,
the cochleae were immunolabeled with neurofilament 200 kDa
to label the nerve fibers and To-Pro3, a nuclear stain. SGNs
from the basal turn of a typical control cochlea (Fig. 5A) had
large round soma, cytoplasm heavily labeled with neurofila-
ment (green) and a large, oval-shaped nucleus in the center of
the soma. The ANFs labeled with neurofilament appeared as
thick fascicles (Fig. 5A). In contrast, the soma of many SGNs
in the 4 mg/kg TMT group appeared shrunken and distorted
and the nucleus was often condensed and fragmented,
morphological features of cells undergoing apoptosis (arrow-
head, Fig 5B). Similar morphological changes were observed
in the SGNs in the 8 mg/kg TMT group, but the changes were
more prevalent and pronounced (Fig. 5C). In addition, most of
the neurites in 8 mg/kg TMT group were missing and the
neurofilament labeling of the cytoplasm tended to be less
intense and less uniform than that seen in controls and in the
4 mg/kg TMT group.
4. Discussion
TMT is widely used for production of plastics in the
chemical industry and is an established occupational and
environmental health hazard (Borghi and Porte, 2002; Geloso
et al., 2011). The first two TMT poisoning cases were reported
in 1978 and by 2010 there were more than 1849 cases and 23
deaths recorded from TMT intoxication (Tang et al., 2010).
TMT is a potent neurotoxin that mainly damage neurons in
CNS (Trabucco et al., 2009). Human TMT cases develop a
“limbic-cerebellar syndrome”; the clinical features include
hearing loss, disorientation, amnesia, aggressiveness,
disturbed sexual behavior, complex partial and tonic-clonic
seizures, ataxia and mild sensory neuropathy (Besser et al.,
1987). Because of the obvious neurobehavioral changes,
most research related to TMT has focused on damage to the
CNS with little attention to other less obvious conditions suchFig. 5. Representative confocal images showing spiral ganglion neurons (SGNs) in t
group and (C) 8 mg/kg TMT group. Note SGN with shrunken soma and condensed
200 kDa (green); nuclei labeled with To-Pro-3 (red).as hearing impairment (Ruppert et al., 1984; Besser et al.,
1987). A limited number of studies have characterized some
aspects of TMT ototoxicity (Young and Fechter, 1986; Crofton
et al., 1990), but a complete understanding of the functional
and structural changes associated with different doses of TMT
is lacking.
Our results show that a single 4 mg/kg dose of TMT did not
lead to OHC or IHC loss. However, the 4 mg/kg dose of TMT
caused a moderate CAP threshold shift at 7 d post-treatment,
but CAP thresholds had recovered to pre-treatment values by
28 d post-treatment. Despite the lack of damage to IHCs or
OHC and lack of permanent CAP threshold shift, the 4 mg/kg
dose of TMT greatly reduced the number of cochlear nerve
fibers at 7 d post-treatment, especially the fibers innervating
the IHCs, which are predominantly type I ANFs (Spoendlin,
1981). There are several possible explanations for the tem-
porary increase in CAP thresholds at 7 d post-treatment and
complete recovery of CAP thresholds at 28 d post-treatment.
One possibility is that the temporary CAP threshold shift at
7 d post-treatment is due to transient damage to the ANFs
followed by the subsequent repair of the type I ANF terminals
that make synaptic contacts with the IHCs (Pujol and Puel,
1999; Wang and Green, 2011). Thus, the repair or regenera-
tion of the type I ANFs and their synaptic connections with
IHCs may contribute to recovery of hearing sensitivity. To test
this hypothesis, additional, in depth morphological studies are
needed to determine if ANFs can regenerate after TMT
treatment. On the other hand, the small loss of SGNs after the
4 mg/kg dose of TMT and the large loss following 8 mg/kg of
TMT indicate that TMT is highly neurotoxic and that the
ANFs and SGNs are the most vulnerable structures to oto-
traumatic insults. This interpretation is consistent with recent
studies showing that the low and medium spontaneous rate
ANFs are the most susceptible to noise-induced hearing loss
(Kujawa and Liberman, 2009; Lin et al., 2011). Moreover,
selective destruction of low and medium spontaneous rate
ANFs seems to have little effect on CAP threshold. Thus, the
complete recovery of CAP thresholds after 4 mg/kg TMT
treatment does not necessarily mean that there is absence of
cochlear pathology. Indeed, there is evidence of moderate
ANF and SGN damage even after the 4 mg/kg TMT treatmenthe basal turn of the cochlea 7 d post-treatment. (A) Controls. (B) 4 mg/kg TMT
nuclei (arrowheads). Specimens labeled with an antibody against neurofilament
125J. Yu et al. / Journal of Otology 11 (2016) 118e126(Figs. 4,5). If the TMT were to selectively damage the high-
threshold ANFs with low and medium spontaneous rates,
this would be expected to reduce the suprathreshold amplitude
of the CAP, but have little effect on CAP threshold. In current
study, we found that CAP amplitude at 80 dB (SPL) were
significantly decreased at all frequencies 28 days post-TMT in
the 4 mg/kg and 8 mg/kg groups (Fig. 1C, D). This indicate
that although CAP thresholds were restored to near normal
levels at all frequencies except 32 kHz in 8 mg/kg group 28,
the CAP amplitudes were diminished at all frequencies which
likely reflects a prolonged dysfunction in the auditory nerve
fibers. The delayed latencies of CAP at 32 kHz were associ-
ated with a threshold shift in 8 mg/kg group (Fig. 1F). The
increase in latency is likely due to the threshold shift and
damage to the ANFs and SGNs. It is noteworthy that CAP
thresholds at 4, 8, 16 kHz were completely recovered 28 days
post-TMT. However, the latencies at 4, 8, 16 kHz were still
prolonged (Fig. 1F). This suggests a dysfunction of auditory
nerve fibers consistent with the CAP amplitude reduction
(Fig. 1C,D). In any case, our results suggest that low-dose
TMT preferentially damages the ANFs beneath the IHCs
suggesting that type I ANF may be the most susceptible
structures. This result is consistent with previous physiological
studies demonstrating that TMT initially disrupts cochlear
CAP function while more severe damage depresses the CM
potential generated by the OHCs (Fechter et al., 1992).
Based on our in vitro study, TMT preferentially damaged
ANF and SGNs, but had no effect to cochlear sensory hair
cells. In addition, TMT-induced damage to SGN was always
associated with nuclear shrinkage, condensation, or fragmen-
tation, neuroanatomical features of apoptosis (Yu et al., 2015).
These findings are very similar to the damage patterns in
current in vivo study, which may suggest that the neurotoxic
effects of TMT are more severe than its toxic effects to sensory
hair cells in the inner ear.
At the higher 8 mg/kg dose, TMT caused significant loss of
cochlear hair cells, nerve fibers and SGNs. TMT-induced hair
cell loss was greatest near the base of the cochlea and OHC
loss was more severe than IHC loss. This pattern of damage is
similar to that seen with aminoglycoside antibiotics (Forge and
Schacht, 2000). However, aminoglycoside antibiotics such as
gentamycin and neomycin mainly damage hair cells, but have
limited effect on SGNs and nerve fibers (Ding and Salvi,
2005). Also with the 8 mg/kg dose of TMT, neural damage
was most severe at the base of the cochlea consistent with the
pattern of hair cell loss. SGN loss was observed mainly in the
hook region of cochlea where 40e50% of the SGNs were
missing. These results indicate that TMT initially damages
ANFs and SGNs in the base of the cochlea, but as the dose
increases sensory cell loss begins to occur with OHCs being
more vulnerable than IHCs.
While we did not explore the mechanisms of TMT-induced
damage in detail, confocal microscopy revealed considerable
nuclear condensation and soma shrinkage in SGNs, morpho-
logical hallmarks of apoptosis. These results are consistent
with previous in vitro findings showing TMT-induced SGN
damage occurs by apoptosis as reflected by caspase-3activation (Yu et al., 2015). Studies with neural cell lines and
primary cultures suggest that TMT-induced apoptosis is
associated with glutamate excitotoxicity, oxidative stress,
intracellular calcium overload, and mitochondrial damage
(Jenkins and Barone, 2004; Piacentini et al., 2008; Geloso
et al., 2011). Given that TMT-induced CAP dysfunction is
prevented by antioxidants (Clerici, 1996), it seems likely that
reactive oxygen species (ROS) play a major role in TMT-
induced SGN damage. Since glutamate is the putative neuro-
transmitter at the synapse between IHC and type I SGN, TMT-
induced excitotoxicity may account for the massive degener-
ation of nerve fiber terminals below the IHC (Pujol and Puel,
1999).
In summary, our results suggest the synapse between the
IHC and type I SGNs may be the most susceptible to TMT-
induced cochlear damage. TMT damage is dose and loca-
tion dependent. As the dose of TMT increases, damage
spreads to the OHCs and IHCs in the base of the cochlea.
TMT-induced cell death is likely occurs by apoptosis; how-
ever, the exact mechanisms by which this occurs will require
further study.
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